Randy Kimple, MD, PhD
Dr. Kimple’s work aims at developing a new treatment for patients with head and neck cancer to treat and reduce radiation-induced xerostomia.
Over the last year, Dr. Kimple’s research focused on using mesenchymal stem cells to treat radiation-induced xerostomia. Working with Dr. Jacques Galipeau and the Program for Advanced Cell Therapy, Dr. Kimple seeks to study the MSCs from head and neck cancer patients who have completed radiation to ensure they are capable of being used as a personalized therapy. This pilot study will lay the groundwork for a FDA-IND application and a first-in human clinical trial to treat xerostomia.